longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BLLN

BLLN
----

LongbridgeAI

BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026 | BLLN Stock News

StockTitan
Jul 15, 2026 at 04:05 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

BillionToOne, Inc. (NASDAQ: BLLN) announced it will release its financial results for the second quarter ended June 30, 2026, after market close on August 5, 2026. The company will host a conference call at 1:30 pm PT / 4:30 pm ET to discuss these results. Analysts are invited to register in advance, and a live webcast will be available on the company's investor relations website.

See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google

Add on Google

MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, August 5, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.

Analysts planning to participate in the conference call should register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast for interested listeners will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.

About BillionToOne

Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.

Investor Contact
ir@billiontoone.com

Media Contact
billiontoone@moxiegrouppr.com


Login to unlock968characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Billiontoone

Billiontoone

BLLN.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--